The Senescence Program is Reduced in Proteasome Inhibitor Bortezomib-Resistant PC3 Prostate Cancer Cell Line

Objective: Senescence may act as an antitumor mechanism by preventing the proliferation of cancer cells. Here we investigated the hypothesis that PC3 prostate cancer cells resistant to bortezomib respond differently to proteasomal inhibition with respect to induction of the senescence program as com...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ertan Kanbur, Semih Şeker, Ferah Budak, Azmi Yerlikaya
Format: Artigo
Jezik:Inglês
Izdano: Istanbul University Press 2023-06-01
Serija:European Journal of Biology
Teme:
bortezomib
cancer
prostate
proteasome
p16 ink4a
senescence
Online dostop:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/B218A92BA9454949935DB450BDB7C8DC
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki